MUC5AC protects pancreatic cancer cells from TRAIL-induced death pathways

  • Authors:
    • Hirotaka Hoshi
    • Tetsuji Sawada
    • Motoyuki Uchida
    • Hiroko Iijima
    • Kenjiro Kimura
    • Kosei Hirakawa
    • Hideki Wanibuchi
  • View Affiliations

  • Published online on: January 3, 2013     https://doi.org/10.3892/ijo.2013.1760
  • Pages: 887-893
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

We have previously reported that a specific siRNA transfected MUC5AC could knockdown MUC5AC expression and suppress in vivo tumor growth and metastasis, although it had no effects on in vitro cell growth, cell survival, proliferation and morphology. In the present study, we investigated which host immune cells induced these effects and how the effects were induced using immunocyte-depleted animal models. The tumor growth of SW1990/si-MUC5AC cells, which show no tumor growth when implanted subcutaneously into a nude mouse, was recovered when neutrophils were removed by anti-Gr-1 mAb administration. This result suggests that MUC5AC may suppress the antitumor effects of neutrophils by allowing tumor cells to escape the host immune system. Subsequently, we investigated the effects of MUC5AC on apoptosis induction mediated by TNF-related apoptosis-inducing ligand (TRAIL), one of the antitumor mechanisms of neutrophils. SW1990/si-MUC5AC cells showed significantly increased active caspase 3 expression after the addition of TRAIL. On the other hand, SW1990/si-mock cells showed no such changes. Our results indicate that MUC5AC inhibits TRAIL‑induced apoptosis in human pancreatic cancer and may serve as an important indicator in diagnosis and prognosis.
View Figures
View References

Related Articles

Journal Cover

March 2013
Volume 42 Issue 3

Print ISSN: 1019-6439
Online ISSN:1791-2423

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
APA
Hoshi, H., Sawada, T., Uchida, M., Iijima, H., Kimura, K., Hirakawa, K., & Wanibuchi, H. (2013). MUC5AC protects pancreatic cancer cells from TRAIL-induced death pathways. International Journal of Oncology, 42, 887-893. https://doi.org/10.3892/ijo.2013.1760
MLA
Hoshi, H., Sawada, T., Uchida, M., Iijima, H., Kimura, K., Hirakawa, K., Wanibuchi, H."MUC5AC protects pancreatic cancer cells from TRAIL-induced death pathways". International Journal of Oncology 42.3 (2013): 887-893.
Chicago
Hoshi, H., Sawada, T., Uchida, M., Iijima, H., Kimura, K., Hirakawa, K., Wanibuchi, H."MUC5AC protects pancreatic cancer cells from TRAIL-induced death pathways". International Journal of Oncology 42, no. 3 (2013): 887-893. https://doi.org/10.3892/ijo.2013.1760